Cite
Li J, Gong L, Zhang R, et al. Fibroblast growth factor 21 inhibited inflammation and fibrosis after myocardial infarction via EGR1. Eur J Pharmacol. 2021;910:174470doi: 10.1016/j.ejphar.2021.174470.
Li, J., Gong, L., Zhang, R., Li, S., Yu, H., Liu, Y., Xue, Y., Huang, D., Xu, N., Wang, Y., Xu, Y., Zhao, Y., Li, Q., Li, M., Li, P., Liu, M., Zhang, Z., Li, X., Du, W., & Wang, N. (2021). Fibroblast growth factor 21 inhibited inflammation and fibrosis after myocardial infarction via EGR1. European journal of pharmacology, 910174470. https://doi.org/10.1016/j.ejphar.2021.174470
Li, Jiamin, et al. "Fibroblast growth factor 21 inhibited inflammation and fibrosis after myocardial infarction via EGR1." European journal of pharmacology vol. 910 (2021): 174470. doi: https://doi.org/10.1016/j.ejphar.2021.174470
Li J, Gong L, Zhang R, Li S, Yu H, Liu Y, Xue Y, Huang D, Xu N, Wang Y, Xu Y, Zhao Y, Li Q, Li M, Li P, Liu M, Zhang Z, Li X, Du W, Wang N. Fibroblast growth factor 21 inhibited inflammation and fibrosis after myocardial infarction via EGR1. Eur J Pharmacol. 2021 Nov 05;910:174470. doi: 10.1016/j.ejphar.2021.174470. Epub 2021 Aug 31. PMID: 34478691.
Copy
Download .nbib